e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The of COPD: or balancing repair (yang) and inflammation (yin)
Soriano J. B., Agusti A.
Source:
Eur Respir J 2008; 32: 1426-1427
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Soriano J. B., Agusti A.. The of COPD: or balancing repair (yang) and inflammation (yin). Eur Respir J 2008; 32: 1426-1427
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The yin and yang of idiopathic pulmonary fibrosis
Source: Eur Respir J , 49 (2) 1602316; DOI: 10.1183/13993003.02316-2016
Year: 2017
The yin and the yang of p27Kip1 as a target for cancer therapy
Source: Eur Respir J 2004; 23: 663-664
Year: 2004
The yin and yang of immunosuppression with inhaled corticosteroids in asthma and COPD
Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target!
Year: 2021
Interaction of hemostasis (H) and immune response (IR) in COPD development
Source: Eur Respir J 2004; 24: Suppl. 48, 122s
Year: 2004
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
The role of regional distribution (RD) of body fat mass (BFM) in fat-bone interactions in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Oxidative stress in patients with COPD: does oxygenotherapy (15 hrs/day) contribute to modify oxidant-antioxidant balance?
Source: Eur Respir J 2002; 20: Suppl. 38, 81s
Year: 2002
Hedgehog-interacting protein
(
HHIP
) polymorphisms and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases
Year: 2011
Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012
LSC - 2020 - Could the overweight influence bronchiectasis (B) exacerbations frequency (EF)?
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020
Ventilatory and metabolic adaptations to cycling (C) and walking (W) in patients with chronic heart failure (CHF)
Source: Eur Respir J 2001; 18: Suppl. 33, 490s
Year: 2001
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008
Placenta growth factor (PlGF) triggers small airway remodeling (SAR) in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Year: 2017
Granulocytic myeloid-derived-supressor cells (GrMDSCs) in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Pro/Con Debate "Muscle dysfunction, systemic inflammation and rehabilitation: is physical activity beneficial in COPD?" - CON
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011
Doctors‘ awareness of the Gold standard framework (GSF) for palliation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - The latest insights in chronic care
Year: 2012
Lymphoid follicles in (very) severe COPD: beneficial or harmful?
Source: Eur Respir J 2009; 34: 219-230
Year: 2009
The effect of posture on ventilation using SLP in healthy subject and patients with Alpha 1 anti-trypsin deficiency (A1AT)
Source: International Congress 2014 – Respiratory function: quality and new technologies
Year: 2014
Evaluation of protease-antiprotease imbalance in moderate COPD without antitrypsin deficiency
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Does tolerance of neuro-muscular electrical stimulation (NMES) relate to gender in patients with an acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2012 - Physiotherapy and rehabilitative interventions applied to different populations with respiratory impairment
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept